ANOVA LAML specific result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 12:30:59 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: LAML specific
Individual drug analysis: 133
Drug details and screening numbers
Drug Name: Doxorubicin
Drug ID: 133
Synonyms: Doxil,Rubex
Brand name: Adriamycin
Target: DNA intercalating
Number of cell lines screened: 875
Screening concentration range(s): 0.004 to 1.024 uM
Statistically significant associations identified = 2
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a12 |
NRAS_mut |
133 |
1 |
1 |
Doxorubicin |
DNA intercalating |
7 |
18 |
0.0237 |
-2.47 |
-0.24 |
2.23 |
2 * |
2.3 ** |
1.5 * |
3.3e-04 |
NA |
5.1e-01 |
3.2 |
a13 |
TP53_mut |
133 |
1 |
1 |
Doxorubicin |
DNA intercalating |
12 |
13 |
0.0237 |
-2.79 |
-0.816 |
1.98 |
1.7 * |
2.4 ** |
1.4 * |
3.45e-04 |
NA |
5.11e-01 |
3.2 |
All-tests volcano plot